Synopsis:- At its FY26 earnings call, a Ludhiana-based special steel manufacturer laid out a decade-long plan to push beyond automotive steel into defence, aerospace, railways and nuclear-grade alloys, alongside a nearly threefold capacity expansion even as the stock...
Synopsis:- A combination of artificial intelligence tools deployed across underwriting, servicing and claims has helped a leading private life insurer save more than Rs.200 crore, even as the company posted double-digit growth across nearly every headline metric in...
Synopsis:- A leading Delhi-NCR developer sold fewer homes in the June quarter than a year ago, yet pre-sales value still grew sharply, a mismatch that traces back to a deliberate shift toward pricier, branded residences rather than any real slowdown in demand. Shares...
Synopsis:- HCL Technologies delivered a Q1 FY27 beat on margins and deal bookings, but the brokerage reaction has been genuinely split, with target prices ranging from Rs. 1,040 to Rs. 1,450 across nine major research houses, reflecting a broader disagreement over...
Synopsis:- SBI Funds Management is bringing India’s largest IPO of the year to market, an entirely secondary sale letting SBI and Amundi cash in a sliver of decades-old holdings, and while the pricing looks reasonable next to listed AMC peers, the real story for...
Synopsis:- Bank of America has initiated coverage on the stock with a Buy rating and a Rs. 5,000 target price, framing the company as India’s leading AI compute OEM on the back of a 15-year Nvidia partnership, an asset-light model, and a projected 40 percent...
Synopsis:- A global brokerage has initiated coverage on a leading auto-tech platform with a Buy rating and a target price implying roughly 38 percent upside, betting on operating leverage to nearly triple EBITDA margins by FY30 even as the company currently monetises...
Synopsis: Azad Engineering and MTAR Technologies both sit inside India’s precision engineering upcycle, feeding into aerospace, defence, and clean-energy supply chains that are being reshaped by indigenisation and the global China+1 shift. Their FY26 numbers,...
Synopsis:- A global brokerage has handed a leading payment card manufacturer its first-ever piece of research coverage, backing it with a Buy rating and a target implying 17 percent upside, built on the company’s dominant market share and a newer IoT and eSIM...
Synopsis:- India’s drug pricing regulator has capped retail prices on 39 additional medicines spanning hypertension, diabetes, cardiovascular disease, HIV, antibiotics, and emergency care, marking the second such intervention in two months, with five major...
